Cargando…
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
Palmitoylethanolamide (PEA) is an endogenous lipid modulator in animals and humans, and has been evaluated since the 1970s as an anti-inflammatory and analgesic drug in more than 30 clinical trials, in a total of ~6,000 patients. PEA is currently available worldwide as a nutraceutical in different f...
Autores principales: | Keppel Hesselink, Jan M, Kopsky, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631430/ https://www.ncbi.nlm.nih.gov/pubmed/26604814 http://dx.doi.org/10.2147/JPR.S93106 |
Ejemplares similares
-
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and
topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013) -
Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study
por: Faig-Martí, Jordi, et al.
Publicado: (2017) -
Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
por: Keppel Hesselink, Jan M., et al.
Publicado: (2015) -
Proximal Median Nerve Compression in the Differential Diagnosis of Carpal Tunnel Syndrome
por: Löppönen, Pekka, et al.
Publicado: (2022) -
The Effect of Carpal Tunnel Release on Neuropathic Pain in Carpal Tunnel Syndrome
por: Sonohata, Motoki, et al.
Publicado: (2017)